Notably, whereas most subtypes such as IFNα4 could temporarily restrict tumor outgrowth, the IFNα9 subtype promotes immune-mediated tumor rejection, effectively curing a subset of mice from disease (16). The gene discussed is IFNA4; the disease is neoplasm.